• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

SetSet Launches Clinician-Approved Platform to Deliver Safe Psychedelic Experiences for Women

by Jasmine Pennic 09/20/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– SetSet, the pioneering platform connecting consumers and medical providers for safe microdosing, has officially launched. 

–  The innovative platform is specifically designed to empower women in navigating psychedelic experiences through community support, therapist-created curriculum, and access to trained practitioners.

Addressing Mental Health Disparities

The launch of SetSet addresses a critical need, as women are disproportionately affected by mental health challenges like anxiety and depression. Many are turning to psychedelics such as psilocybin and ketamine as potential alternatives to conventional pharmaceutical treatments.

A Growing Need for Safe and Informed Psychedelic Use

Despite the rising popularity of psychedelics, a vast majority of users lack access to scientifically backed education and integration support. This is particularly true for women, who stand to benefit significantly from psychedelics but are underrepresented in clinical trials. The high cost of licensed psychedelic support further limits access, pushing many to rely on unreliable online information and potentially increasing the risk of adverse outcomes.

SetSet: Empowering Women in Psychedelic Exploration

SetSet’s platform offers women access to licensed therapists and medical providers who provide expert guidance on setting, dosage, contraindications, and after-care. It also fosters a safe and supportive community where users can share experiences and connect with others on similar journeys. All this is available starting at an affordable $47/month.

Ambitious Growth Plans

SetSet has set ambitious goals for the coming year, aiming to onboard 10,000 founding members, including individuals and healthcare professionals in the U.S. and Canada. To support this expansion, the company is seeking $2M in angel investment from mission-aligned backers. The funds will be used to expand the team, provider network, educational offerings, and proprietary technology.

“Women aren’t adequately supported in the current mental healthcare system and need a safe space to explore alternative options like psychedelics. I’ve seen the lack of education and support firsthand, which is why I created SetSet,” says April Pride, SetSet CEO and Founder, who brings nearly a decade of experience in the cannabis space with three successful exits.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |